The Oncology Molecular Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Oncology Molecular Diagnostics Market?
The market size of oncology molecular diagnostics has seen swift expansion in recent years. The market size was $4.84 billion in 2024 and is projected to reach $5.65 billion in 2025, growing at a compound annual growth rate (CAGR) of 16.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Oncology Molecular Diagnostics Industry?
The Oncology Molecular Diagnostics market is projected to reach a market size of $8.99 billion in 2029, growing at a compound annual growth rate (CAGR) of 12.3%.
Download Your Free Sample of the 2025 Oncology Molecular Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Oncology Molecular Diagnostics Market?
The key drivers in the oncology molecular diagnostics market are:
• Advancements in liquid biopsy methods
• Rise of companion diagnostics in treatment plans
• Integration of artificial intelligence in diagnostics
• Expansion of Next Generation Sequencing (NGS) applications in oncology.
Global Market Segmentation: Identifying Major Oncology Molecular Diagnostics Industry Segments
The oncology molecular diagnostics market covered in this report is segmented –
1) By Product: Instruments, Reagents, Other Products
2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies
3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users
Pre-order the 2025 Oncology Molecular Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Oncology Molecular Diagnostics Market?
The key trends in the oncology molecular diagnostics market are:
• The market is witnessing advancements in liquid biopsy and the rise of companion diagnostics.
• There is a growing integration of artificial intelligence and expansion of next-generation sequencing (NGS) applications.
• The industry is focusing on improving global accessibility and evolving biomarker identification.
• A critical emerging trend is refining the regulatory framework, enhancing technological platforms, and developing patient-centric care models.
Who Are the Top Competitors & Leading Players in the Oncology Molecular Diagnostics Market?
Major companies in the oncology molecular diagnostics market are:
• F. Hoffmann-La Roche AG
• Bayer AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthcare AG
• Becton Dickinson and Company
• Agilent Technologies Inc.
• HTG Molecular Diagnostics Inc.
• Hologic Inc.
• Illumina Inc.
• bioMérieux SA
• Beckman Coulter Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Exact Sciences Corp.
• Bio-Techne Corporation
• OPKO Health Inc.
• Myriad Genetics Inc.
• Guardant Health AMEA
• Veracyte Inc.
• Adaptive Biotechnologies Corp.
• Foundation Medicine Inc.
• Pacific Biosciences of California Inc.
• NanoString Technologies Inc.
• Genomic Health Inc.
Regional Dominance: Which Area Leads the Global Oncology Molecular Diagnostics Market?
The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
